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Hepatic Transplant 
A 45-year-old woman is known to have biliary cirrhosis. first diagnosed at age 
25. Cholesterol level was elevated. as was the level of alkaline phosphatase. but she 
was not icteric. Over the past three years. she has gradually become more icteric. 
with persistent elevation of the level of alkaline phosphatase and with anorexia. 
Episodes of hepatic encephalopathy become more frequent. responding to protein 
restriction and finally to catharsis. lactulose. and neomycin. For the past six months. 
she has nOllced a gradually increased protuberance of her abdomen and an umbilical 
hernia. Two weeks ago. she was hospitalized with increased lethargy. increasing 
abdominal distention, and failure to eat. She is barely arousable; bilirubin level is 
12 mg/dl; alkaline phosphatase. 1600 unitsiL. Serum albumin value is approximately 
1.8 gmldl and there is peripheral edema. 
Consultants: Leonard Makowka, M.D., Ph.D. 
Thomas E. Starzl, M.D., Ph.D. 
GENERAL COMMENTS 
Primary biliary cirrhosis (PBC) or chronic nonsuppurative obstructive cholangitis 
represents one entity in a spectrum of hepatic disorders termed "chronic cho-
Ie static liver disease" that also includes sclerosing cholangitis in adults and biliary 
atresia and intrahepatic cholestasis in children. The progressive loss of bile ducts 
is the feature common to all of these hepatic disorders. (Editor's note: This is 
an unusual but. at least to me. very attractive concept. Evidence as to common 
etiology is as yet not abundant.) The etiology of PBC is unknown. although it 
is thought to be an autoimmune disorder. with antimitochondrial antibodies 
(AMA) being positive in over 90% of the patients. The disease overwhelmingly 
afflicts middle-aged women (female:male ratio of approximately 10: I), as illus-
trated by the present case. 
The disease is characterized clinically by jaundice, pruritus, hepatosple-
nomegaly. early fatigability, and malabsorption, with vitamin deficiencies, mal-
nutrition, and bone disease and fractures of varying severity. Once the end-stage 
of this disease develops, the pa.tient can present with the complications of cirrhosis 
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and hepatic failure. including ascites. encephalopathy. and variceal hemorrhage 
that often represent the terminal events. The diagnosis of PBe is based on these 
clinical findings, accompanied by abnormal biochemical parameters reflecting 
a cholestatic pattern of liver injury, the presence of circulating autoantibodies, 
particularly AMA, increased immunoglobulins (lgM), and an increased com-
plement turnover. 
The exact histologic characterization of PBe is critical, especially when one 
considers orthotopic liver transplantation (OL Tx) for this entity and as it relates 
to the differential diagnosis of posttransplant liver dysfunction. as will be de-
scribed below. The pathologic characteristics have been described to represent 
the stages and progression of the disease, ranging from the early findings of a 
chronic inflammatory process, with lymphocytic infiltration of the portal tracts 
and interlobular bile ducts and granulomata, and finally leading to the end-stage 
findings of an absolute paucity of bile ducts. fibrosis. and frank cirrhosis. 
Previously. medical management has been directed at the prevention, early 
recognition, and treatment of the symptoms and systemic complications of PBe. 
The results of therapy with such agents as penicillamine, chlorambucil, colchi-
cine. and cyclosporine have been disappointing. These approaches have had little 
influence on survival; the progression of the disease is inevitable. and patients 
succumb to liver failure and its complications such as variceal bleeding. 
Orthotopic liver transplantation has revolutionized the approach to and man-
agement of patients with end-stage liver disease. The survival results of this 
procedure have advanced dramatically over the past seven years as a result of 
improved immunosuppression with cyclosporine and improved methods of mul-
tiple organ harvesting and preservation. and with technical refinements in the 
recipient procedure. Now OLTx should be considered the treatment of choice 
for patients with PBe. The survival is excellent, with a projected five-year actuarial 
survival of at least 70% in our group of PBe patients, which represents the 
largest single series of such patients undergoing OLTx (165 out of the first 1,000 
transplant patients during the cyclosporine era). These results are even more 
striking when one considers the survival of those patients treated by alternate 
methods or not at all, and the fact that successful transplantation represents a 
cure allowing the patient to resume, in the majority of cases, a normal life and 
not one of a chronic and relentless disease. In fact, PBe is currently the second 
most common indication for OL Tx in adults at our institution, being exceeded 
only by posthepatic cirrhosis, and represents a primary indication for OLTx Il 
most other transplant centers. 
The patient described here in many respects typifies the ideal candidate (Of 
OLTx. With the currem state of the art, one might argue that liver replacemenl 
should have been considered at an earlier stage of her disease, prior to the moll 
recent marked deterioration in her condition. The preoperative evaluation, ~ 
erative approach, and important postoperative considerations pertaining to this 
case will be outlined. 
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PREOPERATIVE EVALUATION AND CONSIDERATIONS 
Once referred to the transplant center for evaluation as a candidate for OLTx, 
the patient undergoes a thorough and extensive evaluation to determine the 
suitability and fitness for the procedure. A careful history and physical exami-
nation are carried out. Alcohol and/or drug abuse, prior blood transfusions, 
concomitant illnesses. prior surgical procedures, medications, and exposure to 
toxins are important details. Physical examination will offer an estimate of how 
advanced the liver disease is (i.e., the presence of the stigmata of end-stage liver 
disease and cirrhosis), and may also offer clues as to the etiology of the liver 
disease that at times may be very difficult to diagnose (i .e., the presence of 
xanthomata and Kayser-Aeischer rings in PBC and Wilson's disease. respectively). 
The presence and degree of encephalopathy should be documented and 
graded. The presence of hepatic encephalopathy should initiate a search for 
precipitating factors such as dehydration, infection, or gastrointestinal bleeding 
that should all be treated. Spontaneous bacterial peritonitis (SBP) is a very 
important associated finding and must always be considered and ruled out by 
appropriate cultures. The SBP can usually be easily managed with appropriate 
antibiotics. When all other circumstances are appropriate, and the patient is a 
candidate for OLTx, and a suitable donor organ is available, the presence of a 
recent SBP should not be considered a contraindication to OL Tx since SBP 
represents a manifestation of end-stage liver disease. Severe cases of encepha-
lopathy should be managed in an intensive care setting, with consideration being 
given to endotracheal intubation to prevent aspiration. All patients should also 
receive neomycin and lactulose. 
A full battery of blood tests are performed that include blood cell count, 
full coagulation profile. electrolyte studies, liver function tests. glucose level, 
and renal function tests, along with more specialized determinations for specific 
disease entities (i.e. , autoanti bodies, copper and iron studies, etc.). Any evidence 
of coagulopathy should be corrected insofar as possible prior to undertaking any 
invasive procedures. Abnormalities in renal function must be further investigated 
., distinguish the hepatorenal syndrome from both simple dehydration due to 
chronic diuretic therapy and ascites, and intrinsic renal disease. This differen-
liation is extremely important, since renal failure during the posttransplant period 
iDcreases morbidity and mortality. Hepatorenal syndrome is completely revers-
Ible after successful OL Tx. However, OL Tx candidates with significant pre-
_l1ln1JP intrinsic renal disease are best managed by combined liver and kidney 
~Klfpgflants during the same operative procedure. This combined approach to 
KK-ftal~e liver and kidney disease has now been carried out in 18 patients at 
institution with excellent results . 
The functional reserve of the liver can be determined further using an in-
green clearance study, particularly in patients who are not deeply 
--...". Endoscopy of the gastrointestinal tract can be performed to detect 
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esophageal varices and other pathology such as inflammatory bowel disease in 
patients with primary sclerosing cholangitis. Patients with a history of bleeding 
esophageal varices undergo injection sclerotherapy. 
Doppler ultrasonography is used to determine the patency of the portal vein, 
hepatic artery, hepatic veins, and vena cava. Selective angiography is reserved 
for patients whose portal vein cannot be visualized by noninvasive means or for 
patients with previous portasystemic venous shunts in whom the status of both 
the shunt and portal vein are very important technical considerations. A genera! 
evaluation of pulmonary, cardiac, and renal status is carried out to asssess the 
surgical risk and to prepare the patient for major surgery. 
The patient's weight, height, ABO blood group, and ultrasound and/or 
computed tomography (CT) scan determination of the liver volume are the most 
important variables in the selection of a suitable donor. The ultrasound and cr 
scan are also useful to detect the presence of liver tumors and to exclude extra-
hepatic extension. Donor-recipient matching is mainly based on blood type and 
organ size. Although ABO blood group barriers have been violated in emergent 
situations (i.e., fulminant hepatic failure, retransplantation, or in pediatric pa-' 
tients for whom the supply of donor organs is critical), we recommend that fort 
the elective or semielective OLTx, donors of the same ABO blood group 
selected. Knowledge of the recipient liver volume as assessed by ultrasound 
or cr scan has proved to be very helpful in the size matching of the 
organ. The liver volume may be very small in relation to the body weight 
certain hepatic disorders such as postnecrotic cirrhosis, and therefore an 
harvested from a donor of similar body weight as the recipient could prove 
be too large for that recipient, who would better accept a liver from a 
weight donor. Conversely, the liver in diseases such as PBC and 
cholangitis is quite large or oversized, and thus such recipients are able to 
organs from much higher weight donors. It is important to remember that 
ever the liver size, it can always be easily accommodated by a much 
recipient; however, the opposite situation can result in disaster. 
It is important to consider certain "risk factors" and discuss how the 
proach to these have changed. These risk factors have included age, n ..... ·vi .... 
abdominal surgery, previous portasystemic shunt procedures, and the 
of active infection. The presence of extrahepatic acute infection should 
OLTx at the time of the active infection. However, the presence of intraheptl 
sepsis such as cholangitis and hepatic abscesses, as may occur with hepatic 
thrombosis in a transplanted liver, should not be contraindications for 
transplantation. Similarly, as already mentioned, the presence of treated 
taneous bacterial peritonitis, a manifestation of chronic liver disease, ImU'UIIoIj. 
preclude successful OL Tx. 
In the past, an age of 55 years or greater was considered a relative 
traindication to OLTx. The concept of age has undergone a dramatic 
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at our institution over the last two to three years. With careful selection criteria 
and individualization of patient management, and by establishing accurate criteria 
for adequate cardiovascular, pulmonary, and neurologic function, the survival 
results in patients older than 50 years, and even in patients older than 60 years, 
have approached the results in the younger age groups. In fact. in a recent review 
of the first 1.000 liver transplants at our institution, who were immunosuppressed 
with cyclosporine, there were 121 patients between the ages of 50 to 60 years 
old. 47 patients between 60 to 70 years old, and one patient who was 76 years 
old at the time of OL Tx. 
The case of the 76-year-old patient who underwent OLTx illustrates clearly 
the impact that liver transplantation can have on the delivery of health care to 
and the management of geriatric patients; it also highlights the importance of 
considering and evaluating each candidate as an individual. This patient was a 
76-year-old woman with primary biliary cirrhosis who was bedridden because 
of incapacitating bone disease. Jaundice was moderate and the main indication 
for OLTx was her debilitating bone disease. She was carefully evaluated. both 
medically and psychosocially, and there was unanimous agreement at the can-
didate selection committee that she st.ould undergo OLTx. She underwent an 
uneventful transplant procedure, with an uncomplicated postoperative course, 
and was discharged at three weeks after transplantation. She is now about 18 
months posttransplant. doing extremely well at home. with normal liver function, 
and has required no readmissions into the hospital . 
There is no doubt that previous abdominal surgery can increase the difficulty, 
morbidity, and mortality of OLTx. Even simple procedures such as an open liver 
biopsy or a cholecystectomy can influence the blood loss and operative time. 
However, it is the mutilating procedures in the hilum of the liver. such as bile 
duct reconstructions for sclerosing cholangitis and portacaval shunt for bleeding 
esophageal varices, that can convert an otherwise routine and straightforward 
liver transplant procedure into a nightmare. In fact, any portasystemic shunt 
procedure will add tremendously to the complexity and morbidity of OLTx, not 
caly because of the consequences of previous abdominal surgery and adhesions, 
.. also because of marked changes in the quality of the portal vein that can 
with any of these shunt procedures. All of these procedures can at best 
considered palliative; the progression of the underlying liver disease is not 
and rarely do the patients become free from the ravages of a chronic 
!dentless disease state. Liver transplantation is curative, and with the mark-
improved results that have been realized over the last few years, many, if 
all. of the procedures such as portoenterostomy. bile duct reconstruction. 
portasystemic shunts should become obsolete. The results of OLTx will 
. even improve further as candidates are selected at an earlier stage 
disease and as OL Tx is offered to younger patients and prior to undergoing 
Upper abdominal surgical procedures. 
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The indications for OL Tx include a major gastrointestinal (Gl) bleed, a 
history of repeated bouts of encephalopathy, progressive neuropathy, refractory 
ascites, a recent precipitous deterioration in liver function and jaundice, severe 
fatigue and pruritus, the rapid progression of incapacitating bone disease, and 
severe wasting. 
Considerations regarding the proper timing of OL Tx are also constantly 
changing and, as already mentioned, OLTx continues to be offered at earlier 
stages of the disease. It has been somewhat easier to time and offer liver trans-
plantation to patients with PBC than for some of the other indications since a 
set of prognostic indices have been developed and accepted at most centers; 
these indices employ the common clinical and pathologic criteria of this entity 
(i.e .. age, total bilirubin level. albumin level. encephalopathy, ascites. GI bleed). 
In our own large series of PBC patients that underwent OLTx, virtually all met 
the criteria for advanced disease that would predict that death would have been 
likely in a year or less without the transplant procedure. 
The patient described in the present case report represents an ideal candidate 
for OLTx. This patient exemplifies most of the common features and charac-
teristics of PBC that have already been outlined above. Moreover. the signs and 
symptoms that she presents will illustrate many common findings in end-stage 
liver disease of any etiology that require hepatic replacement. This patient has 
experienced a rather rapid deterioration of her liver function and exhibits the 
sequelae from it. This type of patient should immediately undergo an evaluation 
as outlined above and immediately be considered for OLTx once a suitable donor 
liver is available. One can easily argue that this patient should have been referred 
for evaluation of liver transplantation at a much earlier stage in her disease. The 
importance of knowing a patient well. and of being able to follow the course of 
a patient's liver disease prior to transplantation. cannot be overemphasized. 
OPERATIVE CONSIDERATIONS 
Liver transplantation for PBC. as for any disease indication, involves the donor 
hepatectomy (organ procurement), recipient hepatectomy, and implantation of 
the new liver into the recipient. 
Donor Procedure 
The techniques for multiple organ retrieval that are currently used are based 
the rapid core cooling of solid organs by the aortic infusion of cold 
containing or colloid-containing solutions, and for the liver, the additional 
fusion of cold solution through the portal venous system. These techniql.M:I. 
along with careful donor monitoring and management, and synchronous 
oration with other transplant teams, have allowed the successful harvesting 
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the liver and/or pancreas, kidneys. and heart or heart and lungs from a single 
brain-dead. heart-beating cadaveric dl)nor. The suitability of a potential liver 
donor has been customarily based on traditional indicators of ischemic injury. 
including liver function tests, parameters of coagUlation, oxygenation. blood 
pressure, level of pressor agent support. the number and duration of cardiac 
arrests. and the cause of death. We have found that these parameters of donor 
assessment can be applied too rigorously and. in fact. may be much less reliable 
in predicting the quality of the liver than has been assumed, thus resulting in a 
potentially high degree of organ wastage. We have liberalized these conservative 
criteria for donor acceptance considerably. and have not suffered a discernible 
penalty. 
The conventional method of liver preservation in recent clinical practice has 
been static. hypothermic (4°C) storage of the liver in Euro-Collins solution. This 
has necessitated the implantation of the liver within a six- to eight-hour period 
after aortic crossclamping in the donor. A major advance in liver preservation 
that has impacted our own clinical practice of liver transplantation has been the 
development of the University of Wisconsin-Lactobionate solution by Dr. Belzer 
and his group. (Editor's note: A very lot;ical approach to increasing donor organ 
survival. this is hopefully but the first in a series of metabolic approaches in 
improving substrate supply to donor organs.) Cold preservation in this new 
solution has resulted in improved quality of organs after revascularization. after 
any duration of preservation; however. more importantly. it has allowed us to 
successfully preserve and transplant livers after more than 20 hours of simple 
cold preservation. 
Recipient Procedure 
The recipient hepatectomy in patients with PBC is usually easier to perform than 
it is in most other instances of adult chronic liver disease. This is especially true 
in the absence of previous upper abdominal surgery. Specific operative findings 
include livers that are considerably larger than normal. marked hilar lympha-
denopathy, and a minimal-to-moderate degree of portal hypertension. These find-
ings. along with the usual absence of major collaterals in the hepatic suspensory 
ligaments and the bare areas of the liver. the usually normal consistency and 
configuration of the suprahepatic and infrahepatic vena cava and the portal vein • 
.ad the usual presence of a normal recipient common bile duct, are all features 
.... render the procedure in PBC technically easier than it is for many of the 
... indications for OL Tx. 
Veno-venous bypass (without systemic heparinization) was developed for 
anhepatic phase of OL Tx as a method of decompressing the temporarily 
systemic venous (vena caval) and splanchnic venous (portal) systems. 
anhepatic phase of OL Tx is the most physiologically turbulent period of the 
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entire procedure. Without veno-venous bypass. there is a massive sequestration 
of blood volume in the peripheral venous circulation of the lower torso and in 
the mesenteric venous circulation, resulting in diffuse edema of the gastrointes-
tinal tract. high renal vein pressure with deterioration of renal function, increased 
bleeding from high pressure in the thin-walled venous collaterals found through-
out the abdomen in patients with portal hypertension, and marked hemodynamic 
instability. 
Veno-venous bypass is now routinely employed in most adults undergoing 
OL Tx in order to reduce these risks and to maintain physiologic stability during 
the anhepatic phase. Blood from the inferior vena cava is drained via a cannula 
placed through the saphenofemoral junction into the cava near the bifurcation 
of the common iliac veins. A second cannula to drain the splanchnic venous 
system is placed end-on into the transected portal vein. These two cannulas are 
joined by a V-type connector. and the blood is returned to the heart through a 
cannula placed in the ipsilateral axillary vein using a nontraumatic. centrifugal 
pump (Biomedicus Inc.). Using such a bypass, it is possible to maintain stable 
hemodynamic parameters similar to prehepatectomy levels. to reduce postop-
erative problems of the bowel and ileus by relieving congestion 0'£ the intestinal 
tract, to avoid renal venous hypertension (thus markedly decreasing the incidence 
of renal failure requiring postoperative dialysis), and to reduce the blood loss 
by preventing the development of high pressure in venous collaterals. 
The technique of veno-venous bypass allows the surgeon to control the 
length of the anhepatic phase and, in this way. the recipient hepatectomy can 
be individualized; certain problems can be addressed such as previous surgery 
or significant portal hypertension. The bypass is established prior to the com-
pletion of the recipient hepatectomy and facilitates the final steps of this pr0-
cedure. particularly the dissection of the vena cava. Once the liver is removed. 
the large bare areas created by the hepatectomy are carefully inspected and 
hemostasis is achieved by oversewing them if necessary. The cuffs of the su-
prahepatic and infrahepatic vena cava are then carefully fashioned and tailored 
for anastomosis. The donor liver, appropriately prepared at the back table in 
cold fluid. is then brought up for implantation. The suprahepatic and intrahepatic 
vena caval cuffs are anastomosed. Prior to the completion of the intrahepatic 
caval anastomosis, the liver is flushed free of potassium and air with cold solutioo 
infused through a cannula in the portal vein. The portal bypass cannula is then 
removed, and the splanchnic venous system is clamped for the next 10 to 15 
minutes while the portal vein cuffs are appropriately fashioned and anastomosed. 
The liver is usually revascularized on portal flow, and the bypass is then c0m-
pletely stopped and the cannulas are removed. Once the liver is revasculariz.ed 
on portal blood and initial rapid hemostasis is achieved, we then proceed with 
the hepatic arterial reconstruction. We prefer an end-to-end anastomosis betwCCD 
the recipient hepatic artery and the donor celiac axis. whenever possible. 
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Our preferred method of vascular anastomoses for the vena cava, portal 
vein. and hepatic artery is an end-to-end anastomosis with continuous nonab-
sorbable monofilament propylene suture. A "growth or expansion factor" is 
employed to prevent suture line stenoses. The running suture is tied several 
millimeters or more from the vessel wall such that when the vessel distends 
under pressure or when vasospasm resolves. the suture can easily be soaked up 
into the vessel, thus preventing deformity at the site of the anastomosis. 
Portal vein thrombosis at one time was considered an absolute or at least a 
relative contraindication to OLTx. However, as the surgical techniques of OLTx 
have been refined over the last few years, our approach to abnormalities and 
thrombosis of the portal vein has become much more aggressive, and these 
situations no longer preclude successful OLTx. We have used vascular grafts of 
donor iliac vein, harvested at the same time as the liver, to reconstruct recipient 
portal vein segments of varying length that are either hypoplastic or thrombosed . 
We have been able to reconstruct the portal vein as far back as the level of the 
confluence of the superior mesenteric and splenic veins under the neck of the 
pancreas. in order to achieve satisfactory splanchnic flow to the liver. 
One technical problem that is unique to patients with PBC undergoing OLTx 
is the fragility and friability of the recipient hepatic artery. The media and sub-
intima have a tendency to separate from the rest of the artery, even with the 
slightest amount of trauma. including the application of vascular clamps in the 
preparation for anastomosis and/or the ligation of the gastroduodenal artery or 
other branches. This can result in fragmentation and intramural dissection of the 
injured vessel proximal to or beyond the level of the left gastric and splenic 
arterial branches. resulting in a suboptimal arterial supply that is unacceptable 
for successful OLTx. In this situation. as in any situation in which the hepatic 
arterial inflow is poor. we use a conduit usually consisting of a free-standing 
pft of donor iliac artery that is anastomosed to the recipient infrarenal aorta 
.-1 is passed through a tunnel posterior to the pancreas and duodenum and 
tMering the hilum so that it can be anastomosed to the donor iliac artery. It 
be noted that intimal dissection occurred in about 20% of the cases in 
large series of PBC patients and required the use of an iliac graft to prevent 
_tluelnt thrombosis. 
After completing the four vascular anastomoses and achieving adequate 
_ ........ , the recipient procedure is completed with the biliary tract recon-
In PBC patients, the biliary reconstruction of choice, and one that is 
possible, is a duct-to-duct choledochocholedochostomy over an external 
stent. The advantages of this method include the preservation of the 
of Oddi and the availability of the T-tube to monitor bile production 
cholangiography. In certain situations, a direct duct-ta-duct repair 
80( be performed, and in these cases an end-to-side Roux-en-Y chole-
"1OS1:01l1IY over an internal stent should be performed. This technique 
~--~----~~-----------
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should be the primary method of biliary reconstruction in patients with preexisting 
extrahepatic biliary tract disease such as sclerosing cholangitis, when there is 
significant size discrepancy between the donor and recipient bile ducts, when 
there is significant bleeding around the bile duct, and for most cases of liver 
transplantation for hepatic tumors in which the recipient dissection includes the 
entire supraduodenaJ lymph node and bile duct areas. Failures of duct-to-duct 
repair are usuaJly best managed by conversion to this method of reconstruction. 
POSTOPERATIVE CONSIDERATIONS 
Postoperative immunosuppression in adults usually consists of a rapid steroid 
taper. beginning with methylprednisolone at 200 mg intravenously the day after 
surgery; this is reduced by 40 mg each succeeding day until a maintenance dose 
of 20 mg per day is reached. Cyclosporine is administered intravenously at a 
dose of 6 mglkg/day in three divided doses. As gastrointestinaJ function nor-
maJizes, the therapy is gradually switched from intravenous to oral cyclosporine 
at 17.5 mglkgiday. The cyclosporine dose is judged on a day-to-day basis by 
assaying the blood concentration of the drug. Acute rejection episodes are treated 
with either steroid boluses and recycles, with monoclonal antibody (OKT). Or-
thoclone. Ortho PharmaceuticaJ Corporation. Raritan. NJ). or with increased 
doses of cyclosporine when indicated. 
The survival in liver transplant patients treated with cyclosporine has im-
proved dramaticaJly. The overall survival rates of the first 1.000 liver transplant 
patients treated with cyclosporine-steroid therapy at our institution were three 
times higher than those of the 170 patients treated with azathioprine and steroids 
before 1980. The five-year actuariaJ survival for this overaJl group of 1,000 
patients was 64%. The projected five-year actuariaJ survivaJ of the group ofPBC 
patients who underwent transplantation at our institution is approximately 70%. 
An aggressive attitude toward and the frequent use of retransplantation has 
had a favorable intluence on the overall survivaJ results of liver transplantation 
at our institution, in particular in the group of patients with PBC. In addition to 
hepatic dysfunction. important factors determining the feasibility of retransplan-
tation include cardiopulmonary status. renaJ function. and the presence or absell(C 
of infection. Since the overaJl general condition of PBC patients prior to the 
initiaJ transplant procedure is usually better than that of patients undergoiq 
transplantation for other indications. retransplantation can often be carried out 
more readily and with better results in the PBC group. In our own series of PBC 
patients undergoing OLTx. the incidence of retransplantation was less than I ill 
5, and the survivaJ rate in this particular group was aJmost 50%. 
Most of the mortality after OL Tx for PBC occurs within the flTSt six IDODIbI 
following transplantation. The causes of death are the same as for OLTx for.., 
disease indication. In the group of PBC patients who underwent transplantlbol 
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at our institution, rejection was the single most important cause of death. either 
because retransplantation was not possible or because retransplantation was not 
successful. Other causes of death included primary graft nonfunction. hepatic 
artery thrombosis, and pneumonia due to bacteria or Pneumocystis carinii. Al-
though the morbidity after OL Tx has decreased considerably over the last few 
years, numerous postoperative complications are experienced by patients after 
this procedure, many of which require surgical intervention. Our review of PBC 
patients undergoing OL Tx revealed that wound infection was the most common 
problem, followed closely by the need for biliary tract revision for anastomotic 
stricture or leak. Gastrointestinal hemorrhage and hemoperitoneum were also 
significant postoperative complications in this group of patients. 
The only potential controversy regarding the application of OL Tx for patients 
with PBC has arisen from another group's experience with liver transplantation 
for PBC in II patients who were immunosuppressed with azathioprine and 
prednisone. Clinical and histopathologic evidence for recurrent PBC was reported 
in 3 of these II patients, However. in our own experience in 165 patients. and 
with follow-up periods ranging from six months to almost 9 1/2 years. we have 
not been able to document recurrent PBC in any of the patients who underwent 
transplantation. Furthermore, we could demonstrate no correlation between the 
presence of AMA titers before and after transplantation and the function of the 
graft. Many histologic similarities exist between PBC and rejection, as well as 
graft vs. host liver disease, and this may therefore account for some confusion 
when diagnosing recurrent disease after transplantation. 
The quality of life after OLTx for PBC has been excellent, with 90% of the 
long-term survivors achieving full rehabilitation. A significant incapacitating 
problem in patients with PBC is osteoporosis, which is thought to be caused by 
• low bone turnover state, Significant bone disease was present in about 40% 
of the PBC patients who underwent liver transplantation at our institution. and 
IppfOximately 20% of these patients were totally incapacitated, There was marked 
improvement in either bone pain or fractures following OL Tx in these patients, 
nen though some patients required prolonged postoperative rehabilitative pro-
pIIllS. A large number of the long-term survivors have returned to either full-
lime or part-time work, and there are patients who have become pregnant and 
11M given birth to normal children. 
There is no doubt that the survival, and particularly the quality of life, of 
with primary biliary cirrhosis who undergo orthotopic liver transplan-
is markedly enhanced when compared to that in patients managed with 
_ard medical therapy. It is expected that these results will even improve 
in the future with better and earlier preoperative selection of candidates, 
illmunosuppression improves or becomes more selective, and as the surgical 
and the postoperative management of these patients becomes more 
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